« Ex FDA Generic BigWig Joins Biggest Generic DrugMaker | Main | What's in Placebos: Who knows? Analysis of randomized, controlled trials »



TrackBack URL for this entry:

Listed below are links to weblogs that reference Pfizer Taps BioCon to Go After Biologics in Pharmerging Markets:


Feed You can follow this conversation by subscribing to the comment feed for this post.


Following the Pfizer investment, Biocon announces a $161 M deal to add manufacturing and R&D in the Bio-Xcell biotech park in Malaysia


Coverage of this story from the PharmaTech Talk blog detailing other Pfizer invetments in India to gain access to that emerging market


More on this from Fierce Biotech detailing price hit Novo Nordisk is taking today - only temporary to be sure

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC

visited 6 states (46.1%)
Create your own visited map of Canada